Private equity firm Advent International has bought bulk drugs maker ZCL Chemicals for Rs 2,000 crore (around $275 million), offering exits to founder-promoters Parikh family and Morgan Stanley Private Equity Asia.
The family has sold 80% of the firm for Rs 1,610 crore. Of this, about 26% will be transferred subject to customary closing conditions and regulatory approvals.
Morgan Stanley, which had picked up around 20% in 2016 for Rs 150 crore, has exited the company with around Rs 390 crore.
This development comes after Advent last month announced that it had signed a definitive agreement to acquire a majority stake in the bulk drugs manufacturer.
Source: VC Circle
By Narinder Kapur
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.